Viewing nowCombinationEtojet Tablets 10/20mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
iCure Co., Ltd.

MFDS item code 202101562 · Approved 2021.02.18 · Insurance code 674402410
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used as an adjunct to dietary measures to reduce total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL-cholesterol levels. It can also be administered alone in homozygous familial hypercholesterolemia patients, either in conjunction with other lipid-lowering therapies or when other treatments are ineffective. This medication should be used alongside appropriate dietary measures after comprehensive assessment of the risk factors and plays an important role in the treatment of dyslipidemia. This helps reduce the risk of cardiovascular diseases caused by hypercholesterolemia and improve blood lipid status.
Administer this medicine once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), an initial dose of 10/40mg once daily is recommended. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine should be administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.
This medication may affect the muscles and can rarely cause serious muscle damage and kidney impairment; therefore, if sudden muscle pain or weakness occurs, one should consult a doctor immediately. It can also affect liver function, so liver function tests should be performed before starting the medication, and liver function should be regularly monitored during treatment. This medication should not be administered to patients with certain liver diseases or with abnormally high liver enzyme levels. Pregnant or potentially pregnant women, as well as nursing mothers, should not take this medication. As it may interact with other medications, patients taking other drugs should inform their doctor or pharmacist, especially when co-administered with certain antibiotics, antiviral drugs, antifungal agents, and immunosuppressants. Elderly patients or those with impaired kidney function are at higher risk of muscle damage and should take special care while taking this medication; dose adjustments may be required. This medication contains lactose and should not be taken by patients with lactose intolerance. Symptoms such as dizziness or drowsiness may occur while taking this medication, so caution is advised when driving or operating machinery. In cases of overdose, there is no specific antidote, and immediate medical attention is required. This medication is not recommended for children as safety and efficacy have not been established. It is important to always take this medication as directed by a doctor, and to consult medical personnel immediately if any abnormal symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and should be kept at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication for a longer period.
White oblong film-coated tablet
30 tablets/box[(10 tablets/PTP packaging (Alu-Alu)x3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
iCure Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.